ArticlePediatric research2026
Relationship between gestational diabetes and term infant hearing outcomes: a cross-sectional data linkage study.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Maternal oral glucose tolerance test parameters and neonatal hearing screening outcomes: a retrospective cohort study.Annals of Saudi medicineObservational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCongenital hearing loss can significantly affect childhood development, yet more than half of affected infants present without identifiable risk factors. A possible association between maternal diabetes and congenital hearing loss has been suggested, although existing evidence is inconsistent. This study examined the relationship between Gestational Diabetes Mellitus (GDM) and congenital hearing loss in term infants using population-level data from Queensland, Australia.
methodsA cross-sectional data-linkage study was conducted using the Queensland Perinatal Data Collection and the QChild newborn hearing screening database from 2014 to 2019. The cohort included term infants ( > 37 weeks) born in Queensland hospitals. Hearing outcomes were linked to maternal and perinatal variables. Multivariable regression models were used to adjust for known risk factors.
resultsAmong 330,778 mother-infant pairs, 11.8% were exposed to GDM. Congenital hearing loss occurred in 0.3% of infants overall, including 13.7% of those exposed to GDM. No significant association was identified between GDM and congenital hearing loss (aOR 1.09; 95% CI 0.90-1.31). Unadjusted analyses suggested higher odds of severe, retrocochlear, and structural hearing loss subtypes among exposed infants.
conclusionGDM was not associated with congenital hearing loss in term infants in this large, population-level cohort. However, heterogeneity across specific audiological phenotypes warrants further investigation. IMPACT: No significant association between Gestational Diabetes Mellitus (GDM) and congenital hearing loss in term infants was found in a setting with universal health care and population screening for both In this context clinicians can be reassured that GDM alone is not associated with increased risk for congenital hearing loss, supporting current screening protocols and resource allocation. In this context clinicians can reassure families that congenital hearing loss due to exposure to GDM alone is unlikely.
Identifiers
41792340What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.